Last reviewed · How we verify
NCT04882592
Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy
Phase 1 trial testing SCiP in Cerebral Palsy in 50 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | SpineX Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 15 May 2021 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SCiP
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
Sponsor
SpineX Inc.
Who can join
Adults 2 to 75, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assessing the effects of noninvasive spinal cord neuromodulation on improving function in individuals with cerebral palsy
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pilot study combining noninvasive spinal neuromodulation and activity-based neurorehabilitation therapy in children with cerebral palsy.
Hastings S, Zhong H, Feinstein R, Zelczer G, et al · · 2022 · cited 14× · PMID 36198701 · DOI 10.1038/s41467-022-33208-w
Verify or expand the search:
- PubMed search for NCT04882592
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SCiP
Trials testing the same drug.
- NCT05720208 — Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Ra · Phase 2 · unknown
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other SpineX Inc. trials
Trials by the same sponsor.
- NCT05720208 — Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Ra · Phase 2 · unknown
- NCT05301335 — Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04882592 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SpineX Inc.
- Last refreshed: 4 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04882592.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing